SMS Pharmaceuticals Ltd.

₹523.85

0.3 (0.1%)

SMSPHARMA Share Price

Pharmaceuticals & Biotechnology

As on November 12, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 4,914.39 Cr

P/E Ratio48.1

Dividend Yield0.08 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	512.83	Bullish
10-DMA	513.6	Bullish
20-DMA	477.28	Bullish
50-DMA	453.87	Bullish
100-DMA	417.29	Bullish
200-DMA	397.48	Bullish

Historical Performance

1 Year

82%

3 Years

334.7%

5 Years

279.9%

10 Years

445.4%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	8,869	7,827	7,093	5,221	5,199
Total Expenditure	7,153	6,438	5,925	4,675	4,053
Other Income	84	62	45	49	52
Operating Profit	1,799	1,452	1,212	594	1,198
Interest	233	185	236	220	192
Depreciation	399	343	315	321	322
Profit Before Tax	1,166	923	661	53	685
Consolidated Net Profit	1,020	691	498	-71	622
Adjusted EPS	11	8	6	-1	7

Compounded Sales Growth

10 Years:8

5 Years:9.5

3 Years:11.2

TTM:2.5

Compounded Profit Growth

10 Years:20.1

5 Years:10.3

3 Years:38

TTM:8.1

Stock Price CAGR

10 Years:18.5

5 Years:30.6

3 Years:63.7

TTM:80.5

Return on Equity

10 Years:3.4

5 Years:7.4

3 Years:5.9

last year:10.9

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	94	89	85	85	85
Total Reserves	7,764	6,149	4,993	4,521	4,618
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,237	1,887	1,660	1,642	1,927
Other Current Liabilities	801	845	654	527	547
Short Term Borrowings	1,509	1,248	1,140	938	679
Total Liabilities	13,878	11,728	10,491	8,797	8,745
Capital Work in Progress	1,216	347	303	332	110
Long Term Loans & Advances	385	159	190	107	93
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	429	366	360	254	394
Total Current Assets	6,634	5,746	5,489	4,107	3,921
Total Assets	13,878	11,728	10,491	8,797	8,745
Adjusted Book Value	84	70	60	54	56

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 48.1, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 63.7%, indicating sustained price appreciation.
The stock carries a beta of 1.1, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹1799 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹8869 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1803891.2

No. of Shares: 3444 (Approx)

Performance:80.4%

803891.2

NIFTY Performance: -2.2%

1 day Top Gainers